04/12/2024
3:16 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2024
3:16 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
7:37 PM | Eagle Pharmaceuticals (Subject)
Tarriff Scott (Filed by)
| Form SC 13G/A | |
03/18/2024
7:00 AM | Eagle Pharmaceuticals (Filer)
| Form NT 10-K | |
03/08/2024
3:49 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
3:40 PM | Eagle Pharmaceuticals (Issuer)
Tarriff Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
6:35 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
02/29/2024
7:23 PM | Cahill Brian Joseph (Reporting)
Eagle Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:44 PM | Eagle Pharmaceuticals (Issuer)
Tarriff Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
7:09 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
2:53 PM | Eagle Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
02/13/2024
7:50 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
12:38 PM | BRANDES INVESTMENT PARTNERS, LP (Filed by)
Eagle Pharmaceuticals (Subject)
| Form SC 13G | |
02/07/2024
8:15 AM | Eagle Pharmaceuticals (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SC 13G | |
02/06/2024
4:09 PM | Cahill Brian Joseph (Reporting)
Eagle Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
1:04 PM | Eagle Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/18/2024
5:56 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/16/2024
6:00 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
4:00 PM | Eagle Pharmaceuticals (Issuer)
Tarriff Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
4:01 PM | Cahill Brian Joseph (Reporting)
Eagle Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
6:00 PM | Eagle Pharmaceuticals (Issuer)
Graves Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
4:15 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K/A | |
12/20/2023
3:34 PM | Cahill Brian Joseph (Reporting)
Eagle Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
4:11 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2023
3:26 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2023
6:36 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2023
6:39 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
4:23 PM | Eagle Pharmaceuticals (Filer)
| Form NT 10-Q | |
11/09/2023
6:57 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2023
3:39 PM | Eagle Pharmaceuticals (Issuer)
Tarriff Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
4:41 PM | Eagle Pharmaceuticals (Issuer)
Graves Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2023
7:49 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2023
6:10 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
4:07 PM | Eagle Pharmaceuticals (Issuer)
Tarriff Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
3:48 PM | Eagle Pharmaceuticals (Subject)
Tarriff Scott (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2023
6:00 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/07/2023
6:20 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2023
5:55 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/17/2023
5:59 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2023
6:06 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2023
5:59 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Mysterious Gold Leverage Just Announced (Ad) World's biggest multibillionaire investor group is buying THIS by the tons
Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers. Find out what it is and see how you can get in with just a few dollars. |
07/24/2023
6:00 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2023
7:00 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/15/2023
5:57 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2023
7:43 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2023
7:23 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/18/2023
4:22 PM | Eagle Pharmaceuticals (Issuer)
Tarriff Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2023
7:34 PM | Eagle Pharmaceuticals (Issuer)
Tarriff Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2023
11:43 AM | Eagle Pharmaceuticals (Subject)
Tarriff Scott (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2023
5:58 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2023
6:16 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
